| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $91.4M | +69.5% |
| R&D Expense | $220.6M | +62.7% |
| SG&A Expense | $61.8M | +23.9% |
| Operating Income | -$191.0M | -45.2% |
| Pre-tax Income | -$160.5M | -27.8% |
| Income Tax | -$13.5M | -55.4% |
| Net Income | -$147.0M | -25.7% |
| EPS (Basic) | -$2.76 | -11.7% |
| EPS (Diluted) | -$2.76 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $618.8M | -12.9% |
| Accounts Receivable | $5.2M | — |
| Current Assets | $639.3M | -11.1% |
| Total Assets | $696.4M | -8.1% |
| Current Liabilities | $56.9M | +13.4% |
| Total Liabilities | $135.0M | -0.7% |
| Stockholders' Equity | $561.4M | -9.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$133.9M | -23.1% |
| Investing Cash Flow | -$2.8M | -497.6% |
| Financing Cash Flow | $45.1M | -81.3% |
| -11.7% |